The Department of Human Oncology at the University of Wisconsin-Madison has chosen RayStation® as its next radiation therapy treatment planning system. The agreement was signed in late December 2016, and the purchase is planned to occur in two phases.
RayStation will be used for external beam treatment planning at the University of Wisconsin and satellite clinics. The agreement also covers affiliates and other partnerships. The purchase includes advanced features such as deformable registration, dose accumulation and adaptive radiation therapy planning. The university will also be an early investigator of TomoTherapy™ planning* in RayStation, which allows for single-platform planning including the Accuray TomoTherapy machines.
John Bayouth, Chief of Radiation Oncology Physics at the Department of Human Oncology, says: “The university is constantly developing and extending its capabilities in the realm of radiation therapy treatment planning. Our intention is to explore plans that leverage the diversity of treatment delivery technologies in our system and determine the optimal approach for each patient.”
Johan Löf, CEO of RaySearch Laboratories, says: “The University of Wisconsin-Madison is well known for its capabilities and long track record in radiation treatment of cancer. The university has conducted pioneering research since the advent of three-dimensional patient imaging and has also spawned several successful companies within treatment planning and delivery. We share a spirit of innovation, and our relationship will lead to further advancement of cancer care. This order, and over 40 more RayStation orders that we received during the fourth quarter, contributed to a very strong finish for 2016.”
* Subject to regulatory clearance in some markets
About the University of Wisconsin-Madison, Department of Human Oncology
The Department of Human Oncology provides comprehensive radiation oncology services to patients, conducts sophisticated research and provides advanced training to the next generation of health professionals. The department, part of the UW School of Medicine and Public Health, has nearly 30 faculty members and around 40 graduate and post-graduate trainees.
About RayStation
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®*, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003.
* Subject to regulatory clearance in some markets
About Accuray
Accuray Incorporated (Nasdaq: ARAY) is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.
More information about RaySearch is available at www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com
Beth Kaplan, Public Relations Director, Accuray
Telephone: +1 (408) 789-4426
bkaplan@accuray.com